Skip to main content

prostate cancer Archives

New therapy options enhance prostate cancer treatment

Jan. 29, 2015— Vanderbilt-Ingram Cancer Center (VICC) patient William Ostman smiled while gazing into a camera lens and declared, “I am a prostate cancer survivor.”

Read more


Vanderbilt-led team studies blood test for prostate cancer

Jan. 5, 2015—Vanderbilt University researcher William Mitchell, M.D., Ph.D., and colleagues in Germany and Canada have demonstrated a method for detecting “cell-free” tumor DNA in the bloodstream.

Read more


Key to prostate cancer resistance

Oct. 29, 2014—A combination of two types of therapy may be more effective in treating castration-resistant prostate cancer.

Read more


Protein’s role in spread of colon cancer studied

Apr. 3, 2014—One of the most formidable weapons in a cancer’s arsenal is the ability to spread to other organs.

Read more


Study links stem cell gene to prostate cancer susceptibility

Mar. 27, 2014—A gene on chromosome 8 — in a region of the genome linked to risk for many types of cancer — is particularly associated with prostate cancer susceptibility, Vanderbilt University researchers have found.

Read more


Predictor of prostate cancer outcomes identified

Dec. 5, 2013—Researchers at Vanderbilt University Medical Center and the University of Alberta in Canada have identified a biomarker for a cellular switch that accurately predicts which prostate cancer patients are likely to have their cancer recur or spread.

Read more


VU to lead prostate cancer treatment research effort

May. 23, 2013—David Penson, M.D., MPH, professor of Urologic Surgery, has received a $2 million research award from the Patient-Centered Outcomes Research Institute (PCORI) to study localized prostate cancer, the second leading cause of death among American men.

Read more


Long-term effects of prostate therapies tracked

Jan. 30, 2013—A new study comparing outcomes among prostate cancer patients treated with surgery versus radiotherapy found differences in urinary, bowel and sexual function after short-term follow-up, but those differences were no longer significant 15 years after initial treatment.

Read more


Study tracks antioxidants’ role in prostate tumor growth

Nov. 15, 2012—Antioxidants promote cell growth in a mouse model of prostate cancer, Vanderbilt researchers report in the journal PLoS ONE. The findings provide insight into the recent controversy regarding antioxidants and prostate cancer prevention.

Read more


Vanderbilt-led study reveals racial disparities in prostate cancer care

Aug. 30, 2012—Racial differences exist in quality surgical care, new research from VICC finds.

Read more


Gene linked to familial prostate cancer

Aug. 23, 2012—A rare, inherited mutation confers an eightfold increased risk of prostate cancer, a recent study shows.

Read more


Proteins may point way to new prostate cancer drug targets

Aug. 2, 2012—Two proteins that act in opposing directions – one that promotes cancer and one that suppresses cancer — regulate the same set of genes in prostate cancer, Vanderbilt-Ingram Cancer Center researchers have found.

Read more


Upcoming Events

15 November
10:00 AM

22 November
10:00 AM

29 November
10:00 AM

MORE EVENTS »